BIOG.LSE The Biotech Growth Trust PLC

Financial Services Capital Markets London Exchange
13.55 GBX
Close of Nov 3, 2026
1,055 1,786
Market cap
GBX 250M
P/E
2.4x
P/B
0.90x
ROE
46.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Mar 2026.

Is BIOG.LSE undervalued?

Graham number

The Graham number of The Biotech Growth Trust PLC cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

The Biotech Growth Trust PLC fundamental analysis

No fundamental analysis for The Biotech Growth Trust PLC yet.

The Biotech Growth Trust PLC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About The Biotech Growth Trust PLC

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the …

Full company profile